Effect of common buffers and heterocyclic ligands on the binding of Cu(II) at the multimetal binding site in human serum albumin.
Visible-range circular dichroism titrations were used to study Cu(II) binding properties of Multimetal Binding Site (MBS) of Human Serum Albumin (HSA). The formation of ternary MBS-Cu(II)-Buffer complexes at pH 7.4 was positively verified for sodium phosphate, Tris, and Hepes, the three most common biochemical buffers. The phosphate > Hepes > Tris order of affinities, together with strong spectral changes induced specifically by Tris, indicates the presence of both Buffer-Cu(II) and Buffer-HSA interactions. All complexes are strong enough to yield a nearly 100% ternary complex formation in 0.5 mM HSA dissolved in 100 mM solutions of respective buffers. The effects of warfarin and ibuprofen, specific ligands of hydrophobic pockets I and II in HSA on the Cu(II) binding to MBS were also investigated. The effects of ibuprofen were negligible, but warfarin diminished the MBS affinity for Cu(II) by a factor of 20, as a result of indirect conformational effects. These results indicate that metal binding properties of MBS can be modulated directly and indirectly by small molecules.
Sokołowska
Magdalena
M
Department of Hygiene, Wrocław Medical University, Mikulicza-Radeckiego 7, 50-345 Wrocław, Poland.
Pawlas
Krystyna
K
Bal
Wojciech
W
Dalton Trans. 2004 Dec 21;(24):4152-60
15573167
J Inorg Biochem. 1996 Dec;64(4):231-46
8916412
Chem Biol Interact. 2000 Jan 3;124(1):1-11
10658898
J Mol Biol. 2005 Oct 14;353(1):38-52
16169013
Eur J Biochem. 1995 Jan 15;227(1-2):524-8
7851432
Inorg Chem. 1996 Jul 17;35(15):4490-4496
11666670
Biochemistry. 1984 Jun 5;23(12):2832-8
6547847
Eur J Biochem. 1994 Feb 15;220(1):193-200
8119287
Mol Pharmacol. 1975 Nov;11(6):824-32
1207674
Clin Chem. 1993 Jan;39(1):48-52
8419057
J Biol Chem. 1998 Jun 12;273(24):14721-30
9614070
J Biol Chem. 1980 Apr 10;255(7):3032-7
7358725
J Inorg Biochem. 2005 Feb;99(2):637-43
15621298
J Inorg Biochem. 2005 Aug;99(8):1653-60
15993944
Biochem Pharmacol. 1988 Oct 15;37(20):3905-9
3190737
J Biol Inorg Chem. 2006 Jul;11(5):559-70
16791640
Biochem Pharmacol. 2002 Nov 1;64(9):1355-74
12392818
Eur J Clin Pharmacol. 1974 Jul 26;7(4):307-13
4850753
J Chromatogr. 1984 Apr 24;288(2):377-88
6736146
Anal Chem. 2005 Mar 1;77(5):1345-53
15732917
Pharmacol Rev. 1981 Mar;33(1):17-53
7027277
J Biol Inorg Chem. 2007 Aug;12(6):913-8
17516096
J Pharm Biomed Anal. 1997 Jul;15(11):1719-24
9260668
Adv Protein Chem. 1994;45:153-203
8154369
FEBS Lett. 1995 Nov 27;376(1-2):1-5
8521951
Eur J Biochem. 2002 Feb;269(4):1323-31
11856367
Eur J Biochem. 1979 Mar;94(2):523-30
428398
Eur J Biochem. 1993 Mar 15;212(3):811-7
8462552
Proc Natl Acad Sci U S A. 2003 Apr 1;100(7):3701-6
12598656
J Inorg Biochem. 1998 Apr;70(1):33-9
9661286
Adv Protein Chem. 1985;37:161-245
3904348
Nature. 1992 Jul 16;358(6383):209-15
1630489
J Inorg Biochem. 2009 Jul;103(7):1005-13
19487034